Kids may not be recommended for COVID-19 vaccination initially, U.S. CDC says

The U.S.
Centers for Disease Control and Prevention (CDC) said on Wednesday that
COVID-19 vaccines may not be initially recommended for children, when
they become available.

who rarely have severe COVID-19 symptoms, have not yet been tested for
any experimental coronavirus vaccine. The CDC said so far early clinical
trials have only included non-pregnant adults, noting the recommended
groups could change in the future as clinical trials expand to recruit
more people.

Pfizer Inc PFE.N
has said it will enroll children, who are capable of passing on the
virus to high-risk groups, as young as 12 in its large, late-stage
COVID-19 vaccine trial, while AstraZeneca
AZN.L has said a sub-group of patients in a large trial will test children between five to 12.

There is no vaccine for COVID-19 yet, but a handful of companies such as Pfizer and Moderna Inc MRNA.O are in final-stage trials of their experimental vaccines.

The CDC also said
on Wednesday that any coronavirus vaccine would, at least at first, be
used under the Food and Drug Administration's emergency use
authorization, and that there could be a limited supply of vaccines
before the end of 2020.

In case of limited supply, some groups may be recommended to get a COVID-19 vaccine first, the CDC said.

vaccines should be rolled out in four phases, with initial supply going
to front-line health workers and first responders, an independent
expert panel tapped by top U.S. health officials recommended earlier
this month.

Related News